Advertisement

Pre-conception Risk Assessment: Medical Problems

  • Priya BhideEmail author
  • Amarnath Bhide
Chapter

Abstract

This chapter aims to summarise the general principles of pre conception risk assessment for medical disorders in women presenting for fertility treatment in terms of benefits, scope, purpose and logistics. It discusses the specific risks as a consequence of the medical disorder to the pregnancy and effects of the pregnancy on the medical disorder. It also discusses the modifications that may be needed to the ART procedure in common medical disorders. Finally it explores evidence for effectiveness of pre conception risk assessment in terms of measurable effects.

Keywords

ART Pre conception Risk assessment Medical disorders 

References

  1. 1.
    ART Factsheet. European Society of Human Reproduction and Embryology (ESHRE). 2014. http://www.eshre.eu/Guidelines-and-Legal/ART-fact-sheet.aspx.
  2. 2.
    Long term trends in fertility treatment. Human Fertilisation and Embryology Authority (HFEA). 2011. http://www.hfea.gov.uk/2585.html.
  3. 3.
    Obesity facts and figures World Health Organisation Fact sheet N°311. European Association for the Study of Obesity (EASO). http://easo.org/obesity-facts-figures.
  4. 4.
    RCOG release: Alcohol in pregnancy: information for you. The Royal College of Obstetricians and Gynecologists; 2015.Google Scholar
  5. 5.
    Diabetes in pregnancy. NICE clinical guideline No. 63. Issued March 2008, modified December 2014. http://www.nice.org.uk/guidance/cg63.
  6. 6.
    Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet Gynecol. 2002;100(5 Pt 1):925–30.PubMedGoogle Scholar
  7. 7.
    Starikov R, Bohrer J, Goh W, Kuwahara M, Chien EK, Lopes V, Coustan D. Hemoglobin A1c in pregestational diabetic gravidas and the risk of congenital heart disease in the fetus. Pediatr Cardiol. 2013;34(7):1716–22.CrossRefPubMedGoogle Scholar
  8. 8.
    Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Cignini P, Cafà EV, Giorlandino C, Capriglione S, Spata A, Dugo N. Thyroid physiology and common diseases in pregnancy: review of literature. J Prenat Med. 2012;6:64–71.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Pre-conception: advice and management. In Clinical Knowledge summaries. National Institute for Health and Care Excellence. Last revised 2015. http://cks.nice.org.uk/pre-conception-advice-and-management.
  11. 11.
    Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21:1081–125.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE clinical guideline CG 107. 2010.Google Scholar
  13. 13.
    Cardiac disease and pregnancy. Good practice No 13. Royal College of Obstetricians and Gynaecologists. June 2011.Google Scholar
  14. 14.
    Lawley CM, Algert CS, Ford JB, Nippita TA, Figtree GA, Roberts CL. Heart valve prostheses in pregnancy: outcomes for women and their infants. J Am Heart Assoc. 2014;3(3), e000953.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Cleuziou J, Hörer J, Kaemmerer H, Teodorowicz A, Kasnar-Samprec J, Schreiber C, Lange R. Pregnancy does not accelerate biological valve degeneration. Int J Cardiol. 2010;145(3):418–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Basude S, Hein C, Curtis SL, Clark A, Trinder J. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. BJOG. 2012;119(8):1008–13.CrossRefPubMedGoogle Scholar
  17. 17.
    Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol. 2011;68(10):1275–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson AG. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev. 2014;10, CD010236.Google Scholar
  19. 19.
    Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette JC. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther. 2005;7(2):69–73.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Jacobsen AE, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital based case control study. J Thromb Haemost. 2008;6:905–12.CrossRefPubMedGoogle Scholar
  21. 21.
    Reducing the risk of thrombosis and embolism during pregnancy and puerperium. Green top guideline N. 37a. RCOG, Nov 2009.Google Scholar
  22. 22.
    Schaefer C, Peters P, Miller RK, editors. Drugs during pregnancy and lactation: treatment options and risk assessment. 2nd ed. Oxford: Academic; 2007.Google Scholar
  23. 23.
    The management of ovarian hyperstimulation syndrome Green top guideline No. 5. RCOG Sept 2006.Google Scholar
  24. 24.
    Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010;10:63.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010;10, CD007950.Google Scholar
  26. 26.
    Winterbottom JB, Smyth RM, Jacoby A, Baker GA. Preconception counselling for women with epilepsy to reduce adverse pregnancy outcome. Cochrane Database Syst Rev. 2008;3, CD006645.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Homerton University HospitalLondonUK
  2. 2.Queen Mary University of LondonLondonUK
  3. 3.Homerton Fertility CentreLondonUK
  4. 4.Department of Obstetrics and Fetal MedicineSt George’s University Hospital Foundation TrustLondonUK

Personalised recommendations